Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections
Data Presented at AAN Show That Lacosamide Significantly Reduced Pain and was Generally Well Tolerated in Patients With Diabetic Neuropathic Pain
Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being
Genetic Engineering & Biotechnology News Reports on Growing Use of Cell-Based Assays
Diverse Coalition of Purchasers Respond to BIO CEO Fly-In: There is Another Side to The Story
Human Genome Sciences Advances Oncology Portfolio
NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect of AACR
Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
Kiadis Pharma Receives Orphan Drug Designation for Rhitol(TM) From the FDA
Phytomedics Inc. Appoints Dr. Laurie Smaldone Alsup, MD., as President and Chief Executive Officer
Increased Light Leads to Early Detection: Caliper Life Sciences Introduces Bioware(R) Ultra Cancer Cell Lines
Excalibur Celebrates PIramed Sale With 'Substantial Cash Return' to Investors
New Data Published in Circulation Showed an Increase in HDL Cholesterol Levels with ACTOS(R) (pioglitazone HCl)
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2008 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.